RESUMO
BACKGROUND: Fibroblast growth factor 21 (FGF21) acts as a potent metabolic regulator. Serum FGF21 levels were significantly higher in obesity and type 2 diabetes mellitus (T2DM) populations. The aim of this study was to evaluate the relationship between serum FGF21 levels and metabolic syndrome (MetS) in T2DM patients. METHODS: Fasting blood samples were obtained from 126 T2DM patients. MetS and its components were defined according to the diagnostic criteria from the International Diabetes Federation. Serum FGF21 concentrations were measured using a commercially available enzyme-linked immunosorbent assay. RESULTS: Among these patients, 84 (66.7%) had MetS. Female gender, hypertension, systolic blood pressure (SBP), diastolic blood pressure (DBP), waist circumference (WC), body weight (BW), body mass index (BMI), body fat mass, fasting glucose, glycated hemoglobin level (HbA1c), triglyceride level (TG), urine albumin-to-creatinine ratio (UACR), insulin level, homeostasis model assessment of insulin resistance (HOMA-IR), and FGF21 levels were higher, whereas high-density lipoprotein cholesterol level (HDL-C) and estimated glomerular filtration rate (eGFR) were lower in DM patients with MetS. Univariate linear analysis revealed that hypertension, BMI, WC, body fat mass, SBP, DBP, logarithmically transformed TG (log-TG), low-density lipoprotein cholesterol (LDL-C) level, log-glucose, log-creatinine, log-UACR, log-insulin, and log-HOMA-IR positively correlated, whereas HDL-C and eGFR negatively correlated with serum FGF21 levels in T2DM patients. Multivariate forward stepwise linear regression analysis revealed that body fat mass (adjusted R 2 change = 0.218; P=0.008) and log-TG (adjusted R 2 change = 0.036; P < 0.001) positively correlated, whereas eGFR (adjusted R 2 change = 0.033; P=0.013) negatively correlated with serum FGF21 levels in T2DM patients. CONCLUSIONS: This study showed that higher serum FGF21 levels were positively associated with MetS in T2DM patients and significantly positively related to body fat mass and TG but negatively related to eGFR in these subjects.
RESUMO
Polyvinylidene fluoride (PVDF) films possess multifunctional ability for piezo/pyro/ferroelectronic applications. One critical challenge of the traditional techniques is the complicated fabrication process for obtaining the poled films. In this work, the PVDF film is facilely prepared by the solution cast on hydrophilically treated substrates. The obtained PVDF films exhibit fairly good pyroelectricity comparable to those fabricated by thermal poling, indicating the film is self-polarized. This result is attributed to the hydrogen-bonding-induced orderly arrangement of the first sub-nanolayer at the bottom, which serves as a "seed layer" and triggered alignment of the rest of the film in a layer-by-layer approach. Additionally, to suppress the piezoelectric noise, a pyroelectric sensor with a novel bilayer structure is developed using the as-prepared PVDF film. Compared with the conventional monolayer sensor, the signal-to-noise ratio of the bilayer one is drastically improved to 38 dB from 18 dB. The above results provide great possibilities for achieving a high-performance wearable pyroelectric sensor with reduced cost and simple procedures.
RESUMO
A new structure of 1.55-µm pillar cavity is proposed. Consisting of InP-air-aperture and InGaAsP layers, this cavity can be fabricated by using a monolithic process, which was difficult for previous 1.55-µm pillar cavities. Owing to the air apertures and tapered distributed Bragg reflectors, such a pillar cavity with nanometer-scaled diameters can give a quality factor of 104-105 at 1.55 µm. Capable of weakly and strongly coupling a single quantum dot with an optical mode, this nanocavity could be a prospective candidate for quantum-dot single-photon sources at 1.55-µm telecommunication band.
